High BRD4 Expression is an Independent Prognostic Factor in Endometrial Carcinoma
Publication
, Conference
Saglam, O; Cao, B; Wang, X; Toruner, G; Conejo-Garcia, J
Published in: MODERN PATHOLOGY
2021
Duke Scholars
Published In
MODERN PATHOLOGY
EISSN
1530-0285
ISSN
0893-3952
Publication Date
2021
Volume
34
Issue
SUPPL 2
Start / End Page
743 / 743
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Saglam, O., Cao, B., Wang, X., Toruner, G., & Conejo-Garcia, J. (2021). High BRD4 Expression is an Independent Prognostic Factor in Endometrial Carcinoma. In MODERN PATHOLOGY (Vol. 34, pp. 743–743).
Saglam, Ozlen, Biwei Cao, Xuefeng Wang, Gokce Toruner, and Jose Conejo-Garcia. “High BRD4 Expression is an Independent Prognostic Factor in Endometrial Carcinoma.” In MODERN PATHOLOGY, 34:743–743, 2021.
Saglam O, Cao B, Wang X, Toruner G, Conejo-Garcia J. High BRD4 Expression is an Independent Prognostic Factor in Endometrial Carcinoma. In: MODERN PATHOLOGY. 2021. p. 743–743.
Saglam, Ozlen, et al. “High BRD4 Expression is an Independent Prognostic Factor in Endometrial Carcinoma.” MODERN PATHOLOGY, vol. 34, no. SUPPL 2, 2021, pp. 743–743.
Saglam O, Cao B, Wang X, Toruner G, Conejo-Garcia J. High BRD4 Expression is an Independent Prognostic Factor in Endometrial Carcinoma. MODERN PATHOLOGY. 2021. p. 743–743.
Published In
MODERN PATHOLOGY
EISSN
1530-0285
ISSN
0893-3952
Publication Date
2021
Volume
34
Issue
SUPPL 2
Start / End Page
743 / 743
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 11 Medical and Health Sciences